NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

CStone to out-license sugemalimab and CS1003 rights to EQRx

By NS Healthcare Staff Writer 28 Oct 2020

CStone’s licencing agreement enables EQRx to develop and commercialise the two late-stage immuno-oncology drugs outside of Greater China

Pfizer gets FDA priority review for abrocitinib to....

Pfizer’s regulatory filing for abrocitinib is based on clinical trial data showing

Bayer to acquire cell and gene therapy firm....

Bayer will add AskBio’s advanced adeno-associated virus (AAV)-based gene therapy platform to

Novartis unveils promising interim Phase 2 data for....

In the Phase 2 study, iptacopan reduced 49% proteinuria, improved plasma C3

Bayer unveils results from Phase 3 finerenone study....

Finerenone is an investigational non-steroidal, selective mineralocorticoid receptor (MR) antagonist, which prevents

Pharmaceuticals

Boehringer Ingelheim, Eli Lilly announce improved cardio-renal outcomes in trial with jardiance
26 Oct 20

Roche, Atea partner to co-develop potential oral Covid-19 treatment
23 Oct 20

CStone to out-license sugemalimab and CS1003 rights to EQRx

Pfizer gets FDA priority review for abrocitinib to....

Bayer to acquire cell and gene therapy firm....

Novartis unveils promising interim Phase 2 data for....

Bayer unveils results from Phase 3 finerenone study....

Pharmaceuticals

Boehringer Ingelheim, Eli Lilly announce improved cardio-renal outcomes in trial with jardiance
26 Oct 20

Roche, Atea partner to co-develop potential oral Covid-19 treatment
23 Oct 20

Gilead’s antiviral remdesivir approved for Covid-19 treatment in US
23 Oct 20

Patient Care

GSK unveils positive Phase ½ data on two RSV candidate vaccines
22 Oct 20

Medtronic’s Intellis DTM SCS therapy shows promise in chronic back pain
21 Oct 20

World Bank approves $12bn funding to support Covid-19 vaccines, test and treatments
14 Oct 20

Nutraceuticals

SGC gets FDA IND approval for gummy-based allergy medication
16 Oct 20

Lygos, Open Book Extracts partner to develop CBG-based nutraceuticals
07 Oct 20

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal
01 Sep 20

NS Healthcare is using cookies

Boehringer Ingelheim, Eli Lilly announce improved cardio-renal outcomes in trial with jardiance26 Oct 20

Roche, Atea partner to co-develop potential oral Covid-19 treatment23 Oct 20

Gilead’s antiviral remdesivir approved for Covid-19 treatment in US23 Oct 20

GSK unveils positive Phase ½ data on two RSV candidate vaccines 22 Oct 20

Medtronic’s Intellis DTM SCS therapy shows promise in chronic back pain 21 Oct 20

World Bank approves $12bn funding to support Covid-19 vaccines, test and treatments 14 Oct 20

SGC gets FDA IND approval for gummy-based allergy medication16 Oct 20

Lygos, Open Book Extracts partner to develop CBG-based nutraceuticals07 Oct 20

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal01 Sep 20

OUR TITLES

Novartis gets FDA Orphan Drug Designation....22 Oct 20

Taking connected healthcare to ‘the next....15 Jun 20

UK needs better PPE stockpiles for....12 Jun 20

Fujifilm to invest $928m to expand....10 Jun 20

Lilly to acquire biotech firm Disarm....16 Oct 20

Bristol Myers to buy cardiovascular therapy....06 Oct 20

Roche acquires Irish biotech firm Inflazome....23 Sep 20

QIAGEN acquires remaining stake in NeuMoDx....18 Sep 20

Takeda signs collaboration, licensing agreement with....09 Oct 20

Fujifilm agrees to manufacture VLP Therapeutics’....01 Oct 20

Samsung Biologics, AstraZeneca enter into global....22 Sep 20

Sanofi, GSK to supply 300 million....21 Sep 20

Boehringer Ingelheim, Eli Lilly announce improved cardio-renal outcomes in trial with jardiance
26 Oct 20

Roche, Atea partner to co-develop potential oral Covid-19 treatment
23 Oct 20

Gilead’s antiviral remdesivir approved for Covid-19 treatment in US
23 Oct 20

GSK unveils positive Phase ½ data on two RSV candidate vaccines
22 Oct 20

Medtronic’s Intellis DTM SCS therapy shows promise in chronic back pain
21 Oct 20

World Bank approves $12bn funding to support Covid-19 vaccines, test and treatments
14 Oct 20

SGC gets FDA IND approval for gummy-based allergy medication
16 Oct 20

Lygos, Open Book Extracts partner to develop CBG-based nutraceuticals
07 Oct 20

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal
01 Sep 20

Novartis gets FDA Orphan Drug Designation....
22 Oct 20

Taking connected healthcare to ‘the next....
15 Jun 20

UK needs better PPE stockpiles for....
12 Jun 20

Fujifilm to invest $928m to expand....
10 Jun 20

Lilly to acquire biotech firm Disarm....
16 Oct 20

Bristol Myers to buy cardiovascular therapy....
06 Oct 20

Roche acquires Irish biotech firm Inflazome....
23 Sep 20

QIAGEN acquires remaining stake in NeuMoDx....
18 Sep 20

Takeda signs collaboration, licensing agreement with....
09 Oct 20

Fujifilm agrees to manufacture VLP Therapeutics’....
01 Oct 20

Samsung Biologics, AstraZeneca enter into global....
22 Sep 20

Sanofi, GSK to supply 300 million....
21 Sep 20